TAMPA, Fla.–(BUSINESS WIRE)–Syniverse®, the “world’s most connected company®” and a premier global technology provider of…
SAN FRANCISCO & NEW ORLEANS–(BUSINESS WIRE)–#AI–Data from several new studies presented this week at the…
Delivers Record 2021 Results Introduces Full-Year 2022 Outlook WESTCHESTER, Ill.–(BUSINESS WIRE)–IAA, Inc. (NYSE: IAA) today…
NEW YORK–(BUSINESS WIRE)–The Arena Group Holdings, Inc., formerly known as theMaven, Inc. (NYSEAMERICAN: AREN) (the…
Revenue of $123.6 million in the Fourth Quarter of 2021, an increase of 18% year-over-year…
Please read the invitation in PDF Attachment Invitation to Novozymes’ Annual Shareholders’ Meeting 2022
Tallinn, Estonia–(Newsfile Corp. – February 11, 2022) – TrustRecruit presents the world’s first AI-enabled verified…
In the YOSEMITE and RHINE studies in diabetic macular edema, at least 60% of eligible…
Nykode Therapeutics has reached the enrollment target of 50 patients in its VB C-02 trial…
CAMBRIDGE, Mass., Feb. 10, 2022 (GLOBE NEWSWIRE) — Genocea Biosciences, Inc. (NASDAQ: GNCA), a biopharmaceutical…
TORONTO–(BUSINESS WIRE)–#FacedriveScarborough–Facedrive Inc. (“Facedrive” or the “Company”) (TSXV:FD), (OTC:FDVRF), a Canadian “people-and-planet first” tech ecosystem…
SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed…
NEW YORK, Feb. 10, 2022 (GLOBE NEWSWIRE) — IN8bio, Inc. (Nasdaq: INAB), a clinical-stage gamma-delta…
Publication demonstrates FDA cleared Acuitas AMR Gene Panel detects and differentiates a broad range of…
SAN DIEGO, Feb. 10, 2022 (GLOBE NEWSWIRE) — Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced…
NEW YORK, Feb. 10, 2022 (GLOBE NEWSWIRE) — Cellectis (Euronext Growth: ALCLS – Nasdaq: CLLS),…
BOSTON, Feb. 10, 2022 (GLOBE NEWSWIRE) — Decibel Therapeutics (Nasdaq: DBTX), a clinical-stage biotechnology company…
Advancing late-stage PH94B clinical program, including: Progress towards topline data readouts for PALISADE-1 and PALISADE-2…
– Partnership leverages Theramex’s leading women’s health capabilities and commercial infrastructure to support the commercialization…
AUSTIN, Texas, Feb. 10, 2022 (GLOBE NEWSWIRE) — Cassava Sciences, Inc. (Nasdaq: SAVA), a clinical-stage…